JPRN-UMIN000029636已完成2 期
A phase 2 trial of Nivolumab in recurrent or metastatic platinum-refractory non-squamous cell carcinoma of the head and neck - HN non-SCC_P2_Nivo
Medical Oncology / Hematology, Department of Medicine Kobe University Hospital and Graduate School of Medicine0 个研究点目标入组 24 人开始时间: 2017年10月20日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Active concomitant malignancy 2.Active infection 3.Central nervous system metastases 4.Carcinomatous Meningitis 5.Infection of HIV, AIDS related disease, and HCV 6.Medical history of immune checkpoint inhibitor 7.Pregnant, breast-feeding, or unwilling to use adequate contraception 8.Treatment of systemic corticosteroid or other immune suppressor 9.Received radiation therapy within 14 days before registration 10.Histroy of interstitial pneumonia 11.History of auto-immune disease 12.hemodialysis 13.Allergy or hypersensitivity reaction for chemothery or other investigational Products
研究者
相似试验
进行中（未招募）
不适用
A Phase II trial of Nivolumab for Metastatic CarcinosarcomaNeoplasmsKCT0004938Yonsei University Health System, Severance Hospital28
进行中（未招募）
不适用
A Study of Nivolumab and Nivolumab Plus Ipilimumab in Recurrent and Metastatic Colon CancerMSI Positive Colorectal CancerMSI Negative Colorectal CancerMedDRA version: 16.1Level: PTClassification code 10061451Term: Colorectal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2013-003939-30-ITBristol-Myers Squibb International Corporation115
进行中（未招募）
不适用
A Study of Nivolumab and Nivolumab Plus Ipilimumab in Recurrent and Metastatic Colon CancerMSI Positive Colorectal CancerMSI Negative Colorectal CancerMedDRA version: 16.1Level: PTClassification code 10061451Term: Colorectal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2013-003939-30-ESBristol-Myers Squibb International Corporation115
进行中（未招募）
1 期
A Study of Nivolumab and Nivolumab Combinations in Recurrent and Metastatic Colon CancerEUCTR2013-003939-30-BEBristol-Myers Squibb International Corporation375
进行中（未招募）
1 期
A Study of Nivolumab and Nivolumab Combinations in Recurrent and Metastatic Colon CancerMSI Positive Colorectal CancerMSI Negative Colorectal CancerMedDRA version: 21.0Level: PTClassification code 10061451Term: Colorectal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2013-003939-30-IEBristol-Myers Squibb International Corporation375